(Q48793944)

English

The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9046987

The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9046987

0 references

1 reference

based on heuristic

inferred from title

computed tomography

1 reference

based on heuristic

inferred from title

author name string

Miller DD

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9046987

Rezai K

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9046987

Alliger R

3

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9046987

Andreasen NC

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9046987

language of work or name

0 references

publication date

1 March 1997

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9046987

Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9046987

41

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9046987

5

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9046987

550-559

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9046987

Negative symptoms in schizophrenia. Definition and reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Regional cerebral blood flow in schizophrenics. Tests using the xenon Xe 133 inhalation method

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Patterns of metabolic activity in the treatment of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Striatal metabolic rate and clinical response to neuroleptics in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Positron emission tomography in schizophrenic patients with and without neuroleptic medication

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Cerebral blood flow in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Reversibility of hemodynamic hypofrontality in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Brain function in psychiatric disorders. I. Regional cerebral blood flow in medicated schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Brain function in psychiatric disorders. III. Regional cerebral blood flow in unmedicated schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Acutely administered haloperidol-induced widespread reduction of regional cerebral blood flow observed from subtraction of brain imaging with single photon emission computed tomography using technetium-99m hexamethyl-propyleneamine oxime

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

The metabolic centroid method for PET brain image analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Regional cerebral blood flow in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Alogia, attentional impairment, and inappropriate affect: their status in the dimensions of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Regional cerebral blood flow in schizophrenia: repeated studies during a psychotic episode.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900110-2

7 January 2021

Identifiers

10.1016/S0006-3223(96)00110-2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9046987

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9046987

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48793944&oldid=2210692579"